Surrey researchers Sign in
A Phase I Study of Intravenous Oncolytic Reovirus Type 3 Dearing in Patients with Advanced Cancer
Journal article   Peer reviewed

A Phase I Study of Intravenous Oncolytic Reovirus Type 3 Dearing in Patients with Advanced Cancer

L Vidal, HS Pandha, TA Yap, CL White, K Twigger, RG Vile, A Melcher, M Coffey, KJ Harrington and JS DeBono
CLINICAL CANCER RESEARCH, Vol.14(21), pp.7127-7137
01/11/2008

Abstract

Science & Technology Life Sciences & Biomedicine Oncology ONCOLOGY THERAPY CARCINOMA EFFICACY TUMORS CYTOTOXICITY INFECTION PATHWAY SAFETY CELLS LIVER
url
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000260732200051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View
Author

Metrics

Details

Usage Policy